Citations

Citations to this article as recorded by  

• Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)
  Sangmo Hong, Won J. Kim, Sungrae Kim, Jung H. Park, Eun S. Kang, Min K. Moon, Jae T. Kim, Ji‐Oh Mok, Ki Y. Lee, Cheol‐Young Park, Chang B. Lee
  Diabetes, Obesity and Metabolism.2026; 28(2): 906.     CrossRef

Citations

Citations to this article as recorded by  

• Surgical Approaches and Perioperative Outcomes in Mediastinal Paragangliomas: A 20-Year Comprehensive Systematic Review
  Nicola Rotolo, Giorgia Cerretani, Sabrina Casagrande, Elisa Nardecchia, Elena Asteggiano, Alberto Colombo, Luca Filipponi, Filippo Piacentino, Schiorlin Ilaria, Federico Fontana
  Cancers.2026; 18(3): 486.     CrossRef
• Successful Laparoscopic Resection of a Giant Para-aortic Pheochromocytoma: A Case Report
  Loay Ghalyoun, Diya E Viju, Khadiga Abdelmonem, Fahed S Khdrawe, Joaquin Picazo-Yeste
  Cureus.2025;[Epub]     CrossRef
• Current Understanding of Carotid Body Paraganglioma Management
  Young-Wook Kim
  Vascular Specialist International.2025;[Epub]     CrossRef
• PHEOCHROMOCYTOMA AND PARAGANGLIOMA: CLINICAL PICTURE, DIAGNOSIS, TREATMENT, FOLLOW-UP AND PROGNOSIS - A LITERATURE REVIEW
  Dominika Żyła, Kornelia Rojek, Andrzej Zuzak, Katarzyna Zych, Sylwia Koziej, Adam Jakubas, Mateusz Korga, Milena Krawczyk
  International Journal of Innovative Technologies in Social Science.2025;[Epub]     CrossRef
• A Prospective Comparative Study of 18F-FDOPA PET/CT Versus 123I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma
  Changhwan Sung, Hyo Sang Lee, Dong Yun Lee, Yong-il Kim, Jae Eun Kim, Sang Ju Lee, Seung Jun Oh, Tae-Yon Sung, Yu-Mi Lee, Young Hoon Kim, Beom-Jun Kim, Jung-Min Koh, Seung Hun Lee, Jin-Sook Ryu
  Clinical Nuclear Medicine.2024; 49(1): 27.     CrossRef
• Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study
  Seung Shin Park, Chang Ho Ahn, Seunghoo Lee, Woochang Lee, Won Woong Kim, Yu‐Mi Lee, Su Jin Kim, Tae‐Yon Sung, Kyu Eun Lee, Jung Hee Kim, Seung Hun Lee, Jung‐Min Koh
  Journal of Internal Medicine.2024; 296(1): 68.     CrossRef
• Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
  Kwan Hoon Jo, Jaewoong Lee, Jaeeun Yoo, Hoon Seok Kim, Eun Sook Kim, Je Ho Han, Yi Sun Jang, Jae-Seung Yun, Jang Won Son, Soon Jib Yoo, Seung Hwan Lee, Dong Jun Lim, Hyuk-Sang Kwon, Seungok Lee, Sungdae Moon, Myungshin Kim
  Annals of Laboratory Medicine.2024; 44(6): 591.     CrossRef
• Raccomandazioni della lista del GdS-Endocrinologia e Malattie del Metabolismo SIPMeL-Choosing wisely: tiroide, anticorpi anti-tiroide, cortisolo, surrene, vitamina D: aggiornamento 2024
  Romolo M. DORIZZI, Vincenzo BRESCIA, Marina VITILLO, Ottavia PORZIO, Federica D’AURIZIO
  La Rivista Italiana della Medicina di Laboratorio.2024;[Epub]     CrossRef
• Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative review
  Seung Min Chung
  Journal of Yeungnam Medical Science.2024; 41(4): 269.     CrossRef
• Clinical and epidemiological characteristics of patients with pheochromocytoma and retroperitoneal paraganglioma
  D. V. Rebrova, N. V. Vorokhobina
  Meditsinskiy sovet = Medical Council.2024; (16): 206.     CrossRef
• Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
  A Ram Hong, Ho-Cheol Kang
  Endocrinology and Metabolism.2023; 38(2): 175.     CrossRef
• Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma– SIZEPASS
  Helena Hanschell, Salvador Diaz-Cano, Alfredo Blanes, Nadia Talat, Gabriele Galatá, Simon Aylwin, Klaus Martin Schulte
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Interleukin-6-producing paraganglioma as a rare cause of systemic inflammatory response syndrome: a case report
  Yin Young Lee, Seung Min Chung
  Journal of Yeungnam Medical Science.2023; 40(4): 435.     CrossRef
• (Extremely rare intrapericardial location of paraganglioma)
  Jaroslav Zajíc, Aleš Mokráček, Ladislav Pešl, Jiří Haniš, Dita Schaffelhoferová
  Cor et Vasa.2023; 65(4): 692.     CrossRef
• A Case of Von Hippel-Lindau Disease With Recurrence of Paraganglioma and No Other Associated Symptoms: The Importance of Genetic Testing and Establishing Follow-Up Policies
  Naoki Okada, Akihiro Shioya, Sumihito Togi, Hiroki Ura, Yo Niida
  Cureus.2023;[Epub]     CrossRef
• KSNM60 in Nuclear Endocrinology: from the Beginning to the Future
  Chae Moon Hong, Young Jin Jeong, Hae Won Kim, Byeong-Cheol Ahn
  Nuclear Medicine and Molecular Imaging.2022; 56(1): 17.     CrossRef
• Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
  Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
  Cancers.2022; 14(8): 1967.     CrossRef
• Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
  A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
  International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
• Pheochromocytoma with Retroperitoneal Metastasis: A Case Report
  建新 崔
  Advances in Clinical Medicine.2021; 11(05): 2239.     CrossRef

Citations

Citations to this article as recorded by  

• GHRH in diabetes and metabolism
  Charlotte Steenblock, Stefan R. Bornstein
  Reviews in Endocrine and Metabolic Disorders.2025; 26(3): 413.     CrossRef
• Biomarkers of GH deficiency identified in untreated and GH-treated Pit-1 mutant mice
  Sarmed Al-Samerria, Huiting Xu, M. Elena Diaz-Rubio, Joseph Phelan, Chi Su, Keer Ma, Anna Newen, Kiana Li, Sayaka Yamada, Ariel L. Negron, Fredric Wondisford, Sally Radovick
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• The TUITEK® patient support program improved caregiver-related behaviors on growth hormone treatment adherence
  Ekaterina Koledova, Pen-Hua Su, Yen-Ju Chen, Aria Assefi, Matias Debicki, Debbie Cooke, Amrit Jheeta, Alexander B. Jones, Jung Eun Moon
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Otolaryngological Problems Among Patients with Growth Hormone Deficiency—A Systematic Review
  Gazala Abdulaziz-Opiela, Paweł Witkowski, Yasmina Późniak, Julia Bajdor, Joanna Bautembach, Małgorzata Myśliwiec, Bogusław Mikaszewski
  Journal of Clinical Medicine.2025; 14(9): 3064.     CrossRef
• Serum levels of leucine-rich α–2 glycoprotein 1 (LRG1), pro-neurotensin (PNT), fatty acid-binding protein 4 (FABP4) and furin in pediatric growth hormone deficiency before and after 1-year growth hormone replacement therapy
  Zhibo Zhou, Yuxin Sun, Zeyan Zheng, Xiaoyuan Guo, Hongbo Yang, Shi Chen, Hui Pan, Huijuan Zhu
  Cytokine.2025; 195: 157022.     CrossRef
• Growth hormone in disease and treatment (Review)
  Saikat Fakir, Md Matiur Rahman Sarker, Madan Sigdel, Nektarios Barabutis
  Medicine International.2025; 5(6): 1.     CrossRef
• Once-Weekly Somapacitan as an Alternative Management of Growth Hormone Deficiency in Prepubertal Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
  Ghina Tsurayya, Cut Alifiya Nazhifah, Muhammad Rahmat Pirwanja, Putri Oktaviani Zulfa, Muhammad Raihan Ramadhan Tatroman, Fajar Fakri, Muhammad Iqhrammullah
  Children.2024; 11(2): 227.     CrossRef
• Efficacy, safety, and patient satisfaction of norditropin and sogroya in patients with growth hormone deficiency: a systematic review and meta-analysis of randomized controlled trials
  Obieda Altobaishat, Mohamed Abouzid, Mostafa Hossam El Din Moawad, Abdulrahman Sharaf, Yazan Al-Ajlouni, Tungki Pratama Umar, Abdallah Bani-salameh, Mohammad Tanashat, Omar Abdullah Bataineh, Abdulqadir J. Nashwan
  Endocrine.2024; 85(2): 545.     CrossRef
• Growth Hormone Deficiency and Growth Hormone Stimulation Test
  胜彬 孙
  Advances in Clinical Medicine.2024; 14(06): 1587.     CrossRef
• Clinical Management of Postoperative Growth Hormone Deficiency in Hypothalamic-Pituitary Tumors
  Pedro Iglesias
  Journal of Clinical Medicine.2024; 13(15): 4307.     CrossRef
• Isolated Growth Hormone Deficiency
  Anastasia Ibba, Chiara Guzzetti, Lavinia Sanfilippo, Sandro Loche
  Endocrines.2024; 5(3): 341.     CrossRef
• L‐DOPA Test in the Diagnosis of Childhood Short Stature: Evaluation of Growth Hormone Peaks Over Time
  Barbara Castelli, Rita De Santis, Simona Carrera, Marco Andrea Malanima, Salvatore De Masi, Stefano Stagi
  Endocrinology, Diabetes & Metabolism.2024;[Epub]     CrossRef
• Hsa_circ_0002473 inhibits GH3 cell proliferation and GH secretion as a competitive endogenous RNA for has-miR-4645-3p
  Kaiyu Pan, Xiaoguang Jiang, Xiaohong Hu, Jianhua Zhan, Chengyue Zhang
  Journal of Pediatric Endocrinology and Metabolism.2024; 37(12): 1054.     CrossRef
• Baseline Clinical Factors Associated with Cessation of Growth Hormone Therapy in Patients with Severe Growth Hormone Deficiency - Real World Evidence
  Nageswary Nadarajah, Emmanuel Ssemmondo, Shani Brooks, Remi Akinyombo, Kazeem Adeleke, Harshal Deshmukh, Thozhukat Sathyapalan
  International Journal of Endocrinology and Metabolism.2024;[Epub]     CrossRef
• Cohort profile: Multicenter Networks for Ideal Outcomes of Rare Pediatric Endocrine and Metabolic Diseases in Korea (OUTSPREAD study)
  Yun Jeong Lee, Chong Kun Cheon, Junghwan Suh, Jung-Eun Moon, Moon Bae Ahn, Seong Hwan Chang, Jieun Lee, Jin Ho Choi, Minsun Kim, Han Hyuk Lim, Jaehyun Kim, Shin-Hye Kim, Hae Sang Lee, Yena Lee, Eungu Kang, Se Young Kim, Yong Hee Hong, Seung Yang, Heon-Seo
  Annals of Pediatric Endocrinology & Metabolism.2024; 29(6): 349.     CrossRef
• Pituitary abnormalities in patients with pediatric growth hormone deficiency in a single tertiary center
  Hyeon Jun Jung, Jeong Rye Kim, Jeesuk Yu
  Annals of Pediatric Endocrinology & Metabolism.2024; 29(6): 365.     CrossRef
• Evaluation of Adult Height in Patients with Non-Permanent Idiopathic GH Deficiency
  Agnese Murianni, Anna Lussu, Chiara Guzzetti, Anastasia Ibba, Letizia Casula, Mariacarolina Salerno, Marco Cappa, Sandro Loche
  Endocrines.2023; 4(1): 169.     CrossRef
• The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma
  Sang Hee Park, Yun Jeong Lee, Jung-Eun Cheon, Choong Ho Shin, Hae Woon Jung, Young Ah Lee
  Annals of Pediatric Endocrinology & Metabolism.2023; 28(2): 107.     CrossRef
• Continuous Glucose Monitoring: A Possible Aid for Detecting Hypoglycemic Events during Insulin Tolerance Tests
  Soo Yeun Sim, Moon Bae Ahn
  Sensors.2023; 23(15): 6892.     CrossRef
• The risk patients with AGHD have of developing CVD
  Eisha Javed, Maha Zehra, Naz Elahi
  International Journal of Cardiology Cardiovascular Risk and Prevention.2023; 19: 200221.     CrossRef
• Diagnosis of GH Deficiency Without GH Stimulation Tests
  Anastasia Ibba, Sandro Loche
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency
  Yun Jeong Lee, Yunha Choi, Han-Wook Yoo, Young Ah Lee, Choong Ho Shin, Han Saem Choi, Ho-Seong Kim, Jae Hyun Kim, Jung Eun Moon, Cheol Woo Ko, Moon Bae Ahn, Byung-Kyu Suh, Jin-Ho Choi
  Endocrinology and Metabolism.2022; 37(2): 359.     CrossRef
• A Radiomics-Based Model with the Potential to Differentiate Growth Hormone Deficiency and Idiopathic Short Stature on Sella MRI
  Taeyoun Lee, Kyungchul Song, Beomseok Sohn, Jihwan Eom, Sung Soo Ahn, Ho-Seong Kim, Seung-Koo Lee
  Yonsei Medical Journal.2022; 63(9): 856.     CrossRef
• Phenotypic spectrum of patients with mutations in CHD7: clinical implications of endocrinological findings
  Ja Hye Kim, Yunha Choi, Soojin Hwang, Gu-Hwan Kim, Han-Wook Yoo, Jin-Ho Choi
  Endocrine Connections.2022;[Epub]     CrossRef
• Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
  Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim
  Endocrinology and Metabolism.2022; 37(6): 839.     CrossRef
• Laron syndrome: clinic, diagnostics (а clinical case)
  P.M. Lіashuk, R.P. Lіashuk, N.I. Stankova, M.B. Kudina
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(3): 193.     CrossRef
• Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
  Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
  Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
• Asian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation
  Byung Kwan Park, Masashi Fujimori, Shu-Huei Shen, Uei Pua
  Endocrinology and Metabolism.2021; 36(3): 553.     CrossRef
• Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
  Byung Kwan Park, Shu-Huei Shen, Masashi Fujimori, Yi Wang
  Investigative and Clinical Urology.2021; 62(4): 378.     CrossRef
• Diagnosis and Treatment of Adult Growth Hormone Deficiency
  Jung Hee Kim
  The Korean Journal of Medicine.2021; 96(5): 400.     CrossRef

The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of acromegaly, and demands for improvements in insurance coverage have been dramatically increasing. In 2017, the KES Committee of Health Insurance decided to publish a position statement regarding the use of somatostatin analogues in acromegaly. Accordingly, consensus opinions for the position statement were collected after intensive review of the relevant literature and discussions among experts affiliated with the KES, and the Korean Neuroendocrine Study Group. This position statement includes the characteristics, indications, dose, interval (including extended dose interval in case of lanreotide autogel), switching and preoperative use of somatostatin analogues in medical treatment of acromegaly. The recommended approach is based on the expert opinions in case of insufficient clinical evidence, and where discrepancies among the expert opinions were found, the experts voted to determine the recommended approach.

Citations

Citations to this article as recorded by  

• Surgical treatment and somatostatin experience in growth hormone-secreting pituitary macroadenoma due to novel AIP mutation
  Kıymet Karagöz, Emine Şeyma Eken, Gülin Karacan Küçükali, Muhammed Erkan Emrahoğlu, Duygu Düzcan Kilimci, Melikşah Keskin, Erdal Kurnaz, Keziban Aslı Bala, Şule Yeşil, Şükriye Yılmaz, Abdullah Sezer, Şenay Savaş Erdeve
  Journal of Pediatric Endocrinology and Metabolism.2025; 38(10): 1103.     CrossRef
• Early Postoperative Predictors of Remission After Transsphenoidal Surgery in Acromegaly: Introduction of the PARS
  Daisuke Tanioka, Ikuya Natori, Yusuke Kobayashi, Shintaro Arai, Masaki Matsumoto, Kenji Sumi, Katsuyoshi Shimizu, Yoichi Morofuji
  Journal of the Endocrine Society.2025;[Epub]     CrossRef
• Hydrogel-fiber-mesh-based 3D cell cultures: A new method for studying pituitary tumors
  Wooju Jeong, Sungrok Wang, Yumin Kim, Soohyun Lee, Minhu Huang, Jaeil Park, Myung-Han Yoon, Chang-Myung Oh, Cheol Ryong Ku
  Smart Materials in Medicine.2024; 5(2): 281.     CrossRef
• Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern
  Kyungwon Kim, Yeongmin Kim, Se Hoon Kim, Ju Hyung Moon, Eui Hyun Kim, Eun Jig Lee, Chang-Myung Oh, Cheol Ryong Ku
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias
  Argyrios Periferakis, Georgios Tsigas, Aristodemos-Theodoros Periferakis, Carla Mihaela Tone, Daria Alexandra Hemes, Konstantinos Periferakis, Lamprini Troumpata, Ioana Anca Badarau, Cristian Scheau, Ana Caruntu, Ilinca Savulescu-Fiedler, Constantin Carun
  Current Issues in Molecular Biology.2024; 46(9): 9721.     CrossRef
• Insulin-Like Growth Factor 1 as a Pillar in Acromegaly: From Diagnosis to Long-Term Management
  Mi Kyung Kim
  Endocrinology and Metabolism.2024; 39(5): 693.     CrossRef
• Diagnosis and Management of Acromegaly: A Consensus Statement of the Pituitary Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
  Luís Miguel Cardoso, Pedro Marques, Maria Teresa Pereira, Ana Agapito, Rui Almeida, Sara Amaral, Maria João Bugalho, Maria Begoña Cattoni, Luísa Cortez, Diana Borges Duarte, João Sequeira Duarte, Fernando Fonseca, Leonor Gomes, Inês Manique, Olinda
  Endocrinology Insights.2024; : 1.     CrossRef
• Acromegaly: Pitfalls in diagnosis and treatment
  Mirjana Doknić
  Galenika Medical Journal.2024; 3(12): 28.     CrossRef
• Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
  A Ram Hong, Ho-Cheol Kang
  Endocrinology and Metabolism.2023; 38(2): 175.     CrossRef
• Growth Hormone Excess: Implications and Management
  Suneela Dhaneshwar, Shrishti Shandily, Vatsalya Tiwari
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2023; 23(6): 748.     CrossRef
• Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
  Montserrat Marques-Pamies, Joan Gil, Elena Valassi, Marta Hernández, Betina Biagetti, Olga Giménez-Palop, Silvia Martínez, Cristina Carrato, Laura Pons, Rocío Villar-Taibo, Marta Araujo-Castro, Concepción Blanco, Inmaculada Simón, Andreu Simó-Servat, Gemm
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
  A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
  International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
• Octreotide in the treatment of acromegaly – the possibilities of high-dose therapy
  I. A. Ilovayskaya
  Meditsinskiy sovet = Medical Council.2022; (10): 148.     CrossRef
• Approach of Acromegaly during Pregnancy
  Alexandru Dan Popescu, Mara Carsote, Ana Valea, Andreea Gabriela Nicola, Ionela Teodora Dascălu, Tiberiu Tircă, Jaqueline Abdul-Razzak, Mihaela Jana Țuculină
  Diagnostics.2022; 12(11): 2669.     CrossRef
• Left to themselves: Time to target chronic pain in childhood rare diseases
  Christine B. Sieberg, Alyssa Lebel, Erin Silliman, Scott Holmes, David Borsook, Igor Elman
  Neuroscience & Biobehavioral Reviews.2021; 126: 276.     CrossRef
• Severe respiratory failure in a patient with COVID-19 and acromegaly: rapid improvement after adding octreotide
  Jacob Luty, LesleAnn Hayward, Melanie Jackson, P Barton Duell
  BMJ Case Reports.2021; 14(8): e243900.     CrossRef
• Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
  Cheol Ryong Ku, Vladimir Melnikov, Zhaoyun Zhang, Eun Jig Lee
  Endocrinology and Metabolism.2020; 35(2): 206.     CrossRef
• Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
  Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, Sung-Woon Kim, Kyeong Hye Park, Kee Ho Song, Seungjoon Oh, Hyun Koo Yoon, Eun Jig Lee, Jung Min Lee, Jung Soo Lim, Jung Hee Kim, Kwang Joon Kim, Heung Yong Jin, Dae Jung Kim, Kyung Ae Lee, Seong-Su Moon, Dong
  The Korean Journal of Medicine.2019; 94(6): 485.     CrossRef